96716 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#2INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#3PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#4Bioactive Collagen Peptides, Method Of Production Thereof, And Use Thereof
#5PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#6Piezoelectric peptide-based materials and piezoelectric devices containing same
#7Functionalized peptides as antiviral agents
#8High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#9FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
#10NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME
#11Preparation and uses of reactive oxygen species scavenger derivatives
#12MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#13Preparation and uses of reactive oxygen species scavenger derivatives
#14INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#15MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#16NDMA RECEPTOR MODULATORS AND USES THEREOF
#17Gelatinase inhibitors and use thereof
#18CXCR antagonistic peptides and uses thereof
#19N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME
#20NMDA RECEPTOR MODULATORS AND USES THEREOF
#21Method for preventing, improving, or treating inflammatory bowel disease
#22NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME
#23Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#24NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#25MULTIFUNCTIONAL OPIOID RECEPTOR LIGANDS AND METHODS OF TREATING PAIN
#26High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#27N-methyl-D-aspartate receptor modulators and methods of making and using same
#28METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANS
#29Peptides, compositions comprising them and uses in particular cosmetic uses
#30Myoblast differentiation promoter
#31CXCR antagonistic peptides and uses thereof
#32Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles
#33NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#34Bifunctional compounds
#35Tunable control of protein degradation in synthetic and endogenous bacterial systems
#36Prodrugs of heteraromatic compounds
#37High penetration drugs and their compositions thereof for treatment of parkinson diseases
#38Polymers, pharmaceutical compositions and methods of synthesizing the same
#39Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#40Hepatitis C virus inhibitors
#41Modulators of protease activated receptors
#42Niacin-peptide having skin whitening activity and use for same
#43DPP-4 inhibitor
#44HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#45Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#46Macrocyclic proline derived HCV serine protease inhibitors
#47GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#48Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#49Therapeutic or preventive agent for diabetes
#50Composition containing peptide ligand that bonds with CXCR2 for treating infective and inflammatory diseases
#51Hepatitis C virus inhibitors
#52NMDA receptors modulators and uses thereof
#53Hemiasterlin derivatives and uses thereof in the treatment of cancer
#54Native chemical ligation at serine and threonine sites
#55PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#56Macrocyclic proline derived HCV serine protease inhibitors
#57Prodrugs of heteraromatic compounds
#58ANTIOXIDANT AGENT
#59Inhibitors of mammalian tight junction opening
#60Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
#61ORGANIC COMPOUNDS AND THEIR USES
#62Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#63Hemiasterlin derivatives and uses thereof in the treatment of cancer
#64Peptides directed for diagnosis and treatment of amyloid-associated diseases
#65Selective substrates for matrix metalloproteinases
#66Urea-containing peptides as inhibitors of viral replication
#67Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#68Antibody Binding Affinity Ligands
#69Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#70ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#71Hemiasterlin derivatives and uses thereof in the treatment of cancer
#72Synthetic polypeptide-containing bioapplicable material and film-forming material
#73Pyrrolidine melanocortin-specific compounds
#74Polypeptide having collagen-like structure
#75Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#76Thio-containing inhibitors of aminopeptidase P, and compositions thereof
#77Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#78Peptides directed for diagnosis and treatment of amyloid-associated disease
#79Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use
#80Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
#81Hemiasterlin derivatives and uses thereof
#82Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
#83Selective substrates for matrix metalloproteinases
#84Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
#85Proline compounds as Granzyme B inhibitors
#864-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use